
Sign up to save your podcasts
Or


Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
1616 ratings
Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards
See omnystudio.com/listener for privacy information.

960 Listeners

402 Listeners

1,177 Listeners

2,179 Listeners

1,986 Listeners

424 Listeners

969 Listeners

790 Listeners

193 Listeners

64 Listeners

213 Listeners

1,301 Listeners

63 Listeners

30 Listeners

65 Listeners

429 Listeners

4 Listeners

58 Listeners

233 Listeners

229 Listeners

64 Listeners

88 Listeners

78 Listeners

81 Listeners

83 Listeners

397 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners